United Kingdom· GB-APID-45211611000001106
Aucatzyl 410million cells dispersion for infusion bags
A obecabtagene autoleucel product containing obecabtagene autoleucel, registered in United Kingdom by Autolus Ltd. The same ATC class is registered in 7 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Obecabtagene autoleucel is registered in 7 of 19 countries.
Countries holding a registration under ATC L01XL12 (obecabtagene autoleucel), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 4 of them publish a price we can compare per daily dose
Obecabtagene autoleucel · ATC L01XL12
7 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Obecabtagene autoleucel
- Manufacturer
- Autolus Ltd
- Country
- United Kingdom (GB)
- ATC code
- L01XL12
- ATC class
- Obecabtagene autoleucel
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Obecabtagene autoleucel in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumAucatzyl 410 10*6 cellsAutolus
- CzechiaAUCATZYLAutolus GmbH, Weil am Rhein
- FinlandAucatzylAutolus GmbH
- IrelandAucatzyl 410 × 106 cells dispersion for infusionAutolus GmbH
- IcelandAucatzylAutolus GmbH
- NetherlandsAucatzyl 410 × 106 cellen dispersie voor infusieAutolus GmbH
- PolandAucatzylAutolus GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Aucatzyl
- Liechtenstein · Aucatzyl
- Norway · Aucatzyl
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7eab3d0f-e9f7-4269-b91a-f2e22f3f898c GET /v1/drugs/7eab3d0f-e9f7-4269-b91a-f2e22f3f898c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "45211611000001106",
"desc": "Aucatzyl 410million cells dispersion for infusion bags (Autolus Ltd)",
"form": "Dispersion for infusion",
"vpid": "45391811000001102",
"source": "dmd",
"vtm_id": "45357911000001106",
"strength": "410 million cells",
"substance": "Obecabtagene autoleucel",
"ingredient": "Obecabtagene autoleucel",
"supplier_code": "44945111000001100"
}See everything about obecabtagene autoleucel.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.